RecruitingNot ApplicableNCT07045623

Comparison of Intensive Versus Standard Care & Education for Dyslipidemia in Hypertension and Diabetes Patients

Sponsor

Saint Vincent's Hospital, Korea

Enrollment

348 participants

Start Date

Apr 1, 2025

Study Type

INTERVENTIONAL

Conditions

Diabetes Mellitus Hypertension Dyslipidemia Primary Prevention

Summary

The prevalence of dyslipidemia is high among patients with hypertension and diabetes mellitus, which increases the risk of cardiovascular disease. However, many patients lack awareness and adherence to treatment and lifestyle modifications. Therefore, a more structured and intensive approach to management and education is required. This study aims to implement intensive dyslipidemia management and education for patients registered at the Hanam City Hypertension and Diabetes Education Center and evaluate changes in blood lipid levels accordingly. Additionally, the study will analyze the impact of intensive education on patients' quality of life, health behaviors, and treatment adherence, ultimately contributing to the development of effective management strategies.

Eligibility

Min Age: 30 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study is comparing intensive cholesterol management and education versus standard care for people with both high blood pressure and diabetes who also have high cholesterol (dyslipidemia). It aims to see whether more aggressive support leads to better heart health outcomes. **You may be eligible if...** - You are between 30 and 80 years old - You are registered in the Hanam City Hypertension and Diabetes Program (South Korea) - You have given written consent to participate **You may NOT be eligible if...** - You have severe kidney disease (stage 4 or worse) - You have liver cirrhosis or severe liver disease - You had a heart attack or acute heart event in the past 6 months - You are pregnant or breastfeeding - You have a psychiatric condition that would affect your ability to participate Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERcentralized management and education group

If assigned to the test group (centralized management and education group), two instructors, one nurse and one nutritionist, will receive an hour of diabetes and high blood pressure 1:15, and will receive an hour of lipid disorder disease and impact 1:15 group education. You will receive a total of 2 hours of education, and you will receive 1 hour of lipid abnormality education conducted in 0 months through a visit in the third month. The dyslipidemia education was conducted in the form of 1:15 small group education or 1:87 group education, which was conducted in 0 months. In particular, the 1:87 form of large-scale education will be operated as a dialogue-oriented lecture that asks and answers questions, and will be conducted by doctors. And in 2 months and 4 months, education on diabetes, high blood pressure, and dyslipidemia will be shortened for 3 minutes through non-face-to-face management phone calls, not face-to-face.

Locations(1)

Catholic University of Korea, ST. Vincent's Hospital.

Gyeonggi-do, Suwon-si, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07045623

Related Trials

A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels, and Participants With Dyslipidemia

NCT069804286 locations

Hypertension Management in Young Adults Personalised by Echocardiography and Clinical Outcome.

NCT037624991 location